Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Late in the second half of Thursday's game, KJ Adams Jr. exited the court at Amica Mutual Pavilion with an apparent non-contact leg injury. REQUIRED READING: Men's March Madness live updates ...

AJ Storr came off the bench to score 15 points in the loss. KJ Adams Jr., a senior forward for Kansas, suffered an injury during the game. It didn't look good when it happened and the update that ...

The initial epicenter within a Texas Mennonite community highlights how declining vaccination rates can lead to rapid disease transmission. While some may believe that abstaining from vaccination ...

RIT’s biomedical sciences BS consists of life sciences core courses combined with flexible electives to customize your degree for medical school or full-time employment. Prepare for Advanced Degrees: ...

Kansas forward KJ Adams exited the Jayhawks’ first-round NCAA Tournament game against Arkansas with what appeared to be a non-contact injury. Losing their star player late in the second half, the ...

A unit of Investor AB, the investment firm controlled by Sweden’s Wallenberg family, will buy medical device maker Nova Biomedical in a $2.2 billion deal. The deal will see Nova Biomedical merge ...

Mayor Adams's flagship tech project has run up a $100 million tab over two and a half years, using dozens of private contractors chosen through methods that avoid oversight and public bidding ...

Struggling with various back and hamstring injuries, Adams hasn't been in a USMNT camp since Copa America 2024, which will not only make this his first appearance since July of last year ...

NEW YORK — New York City Mayor Eric Adams pulled in a paltry $36,121 from just 37 donors for his reelection campaign over the first two months of the year — an anemic haul underscoring how ...

HANALL BIOPHARMA announced on the 18th that it has notified Harbor BioMed of the termination of the license agreement for the autoimmune disease treatment 'batoclimab (HL161).' HANALL BIOPHARMA ...